Related Experiment Video
Updated: Aug 6, 2026
14:35
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
[Secondary prevention after a myocardial infarction]
1Service de Cardiologie, CHU Sart-Tilman, Liège, Belgique.
Revue Medicale De Liege
|August 17, 2006
Summary
Patients after myocardial infarction need aggressive secondary prevention. Evidence supports aspirin, statins, beta-blockers, and ACE inhibitors for better survival and preventing recurrent events.
Area of Science:
- Cardiology
- Pharmacology
- Preventive Medicine
Context:
- Patients post-myocardial infarction face elevated risks of adverse cardiovascular events.
- Secondary prevention strategies are crucial for managing cardiovascular risk factors in these patients.
Purpose:
- To outline evidence-based secondary preventive measures for patients following myocardial infarction.
- To highlight the role of pharmacological agents and lifestyle modifications in improving outcomes.
Summary:
- Randomized controlled trials demonstrate the efficacy of aspirin (or clopidogrel), statins, beta-blockers, and angiotensin-converting enzyme inhibitors in reducing recurrent events and enhancing survival.
- Oral anticoagulants or fibrates may be indicated in specific cases.
- Antioxidant vitamins, folate, and B vitamins have shown disappointing results.
- Lifestyle and dietary changes significantly benefit mortality rates and are essential components of care.
Impact:
- Provides a concise overview of recommended secondary preventive therapies for post-myocardial infarction patients.
- Emphasizes the importance of a multi-faceted approach combining pharmacotherapy and lifestyle modifications.
- Informs clinical practice regarding the selection of effective treatments and the limitations of certain supplements.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...